Health AI Central
Peer-Reviewed Publication
Vet Clin North Am Small Anim Pract2007;37(6):1111-9; vi-ii.November 1, 2007Journal Article

Anticancer vaccines.

Philip J Bergman1
1Brightheart Veterinary Centers, 80 Business Park Drive, Suite 110, Armonk, NY 10504, USA. pbergman@brightheartvet.com
PubMed DOI

Abstract

With the tools of molecular biology and a greater understanding of mechanisms to harness the immune system, effective tumor immunotherapy is becoming a reality. This new class of therapeutics offers a more targeted, and therefore precise, approach to the treatment of cancer. The recent conditional licensure of a xenogeneic DNA vaccine for advanced canine malignant melanoma strongly suggests that i…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.